These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9363821)

  • 1. Inappropriate discharge of an implantable cardioverter defibrillator during atrial flutter and intermittent ventricular antibradycardia pacing.
    Peters W; Kowallik P; Wittenberg G; Scholl C; Meesmann M
    J Cardiovasc Electrophysiol; 1997 Oct; 8(10):1167-74. PubMed ID: 9363821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a novel, single-lead atrial sensing system with a dual-chamber implantable cardioverter-defibrillator system in patients without antibradycardia pacing indications: results of a randomized study.
    Sticherling C; Zabel M; Spencker S; Meyerfeldt U; Eckardt L; Behrens S; Niehaus M;
    Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):56-63. PubMed ID: 21156772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias.
    Gold MR; Sulke N; Schwartzman DS; Mehra R; Euler DE;
    J Cardiovasc Electrophysiol; 2001 Nov; 12(11):1247-53. PubMed ID: 11761411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator.
    Kelly PA; Mann DE; Damle RS; Reiter MJ
    J Am Coll Cardiol; 1994 Jun; 23(7):1531-4. PubMed ID: 8195509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
    J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator.
    Adler SW; Wolpert C; Warman EN; Musley SK; Koehler JL; Euler DE
    Circulation; 2001 Aug; 104(8):887-92. PubMed ID: 11514374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent ICD shocks due to double sensing in patients with bi-ventricular implantable cardioverter defibrillators.
    Al-Ahmad A; Wang PJ; Homoud MK; Estes NA; Link MS
    J Interv Card Electrophysiol; 2003 Dec; 9(3):377-81. PubMed ID: 14618060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of bradycardia pacing and detection of ventricular fibrillation due to far-field atrial sensing in a triple chamber implantable cardioverter defibrillator.
    Vollmann D; Lüthje L; Görtler G; Unterberg C
    Pacing Clin Electrophysiol; 2002 Oct; 25(10):1513-6. PubMed ID: 12418750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undetected ventricular fibrillation in transvenous implantable cardioverter-defibrillators. Prospective comparison of different lead system-device combinations.
    Natale A; Sra J; Axtell K; Akhtar M; Newby K; Kent V; Geiger MJ; Brandon MJ; Kearney MM; Pacifico A
    Circulation; 1996 Jan; 93(1):91-8. PubMed ID: 8616948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing.
    Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P
    Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inappropriate shock because of triple counting in a patient with a subcutaneous implantable cardioverter defibrillator corrected by initiation of dual site left ventricular pacing.
    van Gelder BM; Bracke FA; Simmers T
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):239-40. PubMed ID: 25691559
    [No Abstract]   [Full Text] [Related]  

  • 14. Sensing lead-related complications in patients with transvenous implantable cardioverter-defibrillators.
    Lawton JS; Ellenbogen KA; Wood MA; Stambler BS; Herre JM; Nath S; Bernstein RC; DiMarco JP; Haines DE; Szentpetery S; Baker LD; Damiano RJ
    Am J Cardiol; 1996 Sep; 78(6):647-51. PubMed ID: 8831398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of a prototype passive fixation dual chamber single pass lead for dual chamber ICD systems.
    Butter C; Auricchio A; Schwarz T; Fleck E; Schubert B; Hsu W; Michel U; Neuzner J
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):169-73. PubMed ID: 9990624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between pacing and arrhythmia detection algorithms in the dual chamber implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Interv Card Electrophysiol; 2001 Sep; 5(3):299-308. PubMed ID: 11500585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recording of pacing stimulus artifacts by endovascular defibrillation lead systems: comparison of true and integrated bipolar circuits.
    Menz V; Schwartzman D; Drachman D; Michele JJ; Dillon SM
    J Interv Card Electrophysiol; 1998 Sep; 2(3):269-72. PubMed ID: 9870021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators.
    Swerdlow CD; Schsls W; Dijkman B; Jung W; Sheth NV; Olson WH; Gunderson BD
    Circulation; 2000 Feb; 101(8):878-85. PubMed ID: 10694527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of antitachycardia pacing alerts for the reduction of emergency presentations following shocks in patients with implantable cardioverter-defibrillators: implications for the implementation of remote monitoring.
    Boulé S; Ninni S; Finat L; Botcherby EJ; Kouakam C; Klug D; Marquié C; Brigadeau F; Lacroix D; Kacet S; Guédon-Moreau L
    Europace; 2016 Dec; 18(12):1809-1817. PubMed ID: 26711741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Every cloud has a silver lining: a case of simultaneously appropriate and inappropriate implantable cardioverter defibrillator shock.
    Capulzini L; Mazzotta G; Sorgente A
    Europace; 2013 Nov; 15(11):1683. PubMed ID: 23507819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.